Inge G. Thulin's most recent trade in Merck & Co Inc was a trade of 2,832 Common Stock done at an average price of $88.3 . Disclosure was reported to the exchange on Feb. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Merck & Co Inc | Inge G. Thulin | Director | Purchase of securities on an exchange or from another person at price $ 88.28 per share. | 06 Feb 2025 | 2,832 | 2,932 (0%) | 0% | 88.3 | 250,000 | Common Stock |
Merck & Co Inc | Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 21,228 | - | - | Phantom Stock | |
Merck & Co Inc | Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 18,973 | - | - | Phantom Stock | |
Merck & Co Inc | Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 16,518 | - | - | Phantom Stock | |
Merck & Co Inc | Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 2,635 | 13,293 | - | - | Phantom Stock | |
Merck & Co Inc | Inge G. Thulin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 2,477 | 10,326 | - | - | Phantom Stock |